Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clinical trial commences with Cell Therapeutics' novel paclitaxel

Jan. 20, 2000

Magainin presents new anticancer magainin peptide at H&Q

Jan. 20, 2000

First clinical results with 90Y-DOTATOC indicate antitumor efficacy, some safety problems

Jan. 19, 2000

CKD-731: new fumagillin analogue shows potential as antiangiogenic agent

Jan. 19, 2000

Distamycin derivatives in development at Pharmacia & Upjohn

Jan. 19, 2000

Phase I trial shows excellent safety profile for NeoRx's STR agent

Jan. 19, 2000

Broad patent issued to IntraBiotics covering its protegrin analogues

Jan. 18, 2000

Discovery and use of E6-binding polypeptides for suppressing tumor growth

Jan. 18, 2000

The Liposome Company submits additional Evacet data to FDA

Jan. 18, 2000

SuperGen licenses VTA technology from Techniclone

Jan. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...